nucleoside
Interviews and expert commentary tagged “nucleoside” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
ROY STEIGBIGEL, State University of New York at Stony Brook JOHN W. MELLORS, University of Pittsburgh REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections,
6 March 2007
0:00
Audio Journal of Oncology
Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
RODGER MACARTHUR, Wayne State University, Detroit REFERENCE: Lancet 2006; 368: 2125-35 A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST s
19 January 2007
0:00